JMP Securities maintains Enanta stock with $21 target
JMP Securities reiterated a Market Outperform rating on Enanta Pharmaceuticals (NASDAQ:ENTA) shares with a consistent price target of $21.00. The firm's analysis highlighted the company's solid ...
JMP Securities Sticks to Their Buy Rating for KalVista Pharmaceuticals (KALV)
JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on KalVista Pharmaceuticals (KALV – Research Report) today and set a price ...
JMP reiterates AtriCure stock with $60 target, sees growth
JMP Securities maintained its optimistic stance on AtriCure Inc. (NASDAQ:ATRC), reiterating a Market Outperform rating and a $60.00 price target. The firm's analysts highlighted their anticipation for ...
JMP Securities Sticks to Their Buy Rating for Cytokinetics (CYTK)
JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.
JMP Securities Raises Axon Enterprise, Inc. (AXON) Price Target to $725 on AI & Defense Demand
As the US stock markets were catching up with the tech disruption led by cheap Chinese AI models, US President Donald Trump’s ...
KBC Group NV Boosts Stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)
KBC Group NV increased its holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Free Report) by 66.2% in the fourth ...
Chemistry World12d
Design of experiments: Smarter methods, better results
Even with its well-documented benefits, DoE is often underutilised, especially for solving specialised or constrained ...
University of Delaware2mon
Online Master of Science in Applied Statistics
Exposure to and the opportunity to acquire proficiency in essential technology including Statistical Analysis System (SAS), JMP and R; a JMP software license is included in tuition, a value of more ...